Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah ... [et al.]

Adjuvant trastuzumab has been used in human epidermal growth factor-2 (HER2) breast cancer to improve survival but with concern of cardiotoxicity. Our study is the first to review efficacy and toxicity of adjuvant trastuzumab in Malaysia. Methods: This is a retrospective cohort study on HER2 non met...

Full description

Saved in:
Bibliographic Details
Main Authors: Hasbullah, Harissa H (Author), Bustamam, Anita (Author), Tho, Lye Munn (Author), Phua, Vincent (Author)
Format: Book
Published: Universiti Teknologi MARA Cawangan Selangor, 2018-06.
Subjects:
Online Access:Link Metadata
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Link Metadata

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available